Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer

医学 顺铂 内科学 宫颈癌 紫杉醇 放化疗 外科肿瘤学 化疗 肿瘤科 放射治疗 不利影响 临床终点 癌症 随机对照试验
作者
Yaping Wu,Peng Jiang,Zhiying Chen,Wei Li,Bin Dong,Yongchun Zhang
出处
期刊:BMC Cancer [BioMed Central]
卷期号:24 (1) 被引量:1
标识
DOI:10.1186/s12885-024-12358-8
摘要

Abstract Background Evaluate the efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in treating locally advanced cervical cancer (LACC). Methods Retrospective data was collected from LACC patients who were treated at our institution. These patients were categorized into three groups: the single-agent cisplatin (DDP) chemoradiotherapy group, the paclitaxel plus cisplatin (TP) chemoradiotherapy group, and the nanoparticle albumin-bound (nab-) paclitaxel combined with cisplatin (nPP) chemoradiotherapy group. The primary endpoints were overall survival (OS) and progression-free survival (PFS) and the secondary endpoints were objective response rate (ORR) and incidence of adverse events (AEs). Results A total of 124 patients were enrolled (32 in the DDP group, 41 in the TP group, and 51 in the nPP group). There were differences in OS ( P = 0.041, HR 0.527, 95% CI 0.314–0.884) and PFS ( P = 0.003, HR 0.517, 95% CI 0.343–0.779) between the three groups. Notably, the 2-year OS rate was significantly higher in the nPP group compared to the DDP group (92.2% vs. 85.4%, P = 0.012). The 2-year PFS rates showed a marked increase in the TP group (78.0% vs. 59.4%, P = 0.048) and the nPP group (88.2% vs. 59.4%, P = 0.001) relative to the DPP group, with multiple comparisons indicating that the 2-year PFS rate was significantly superior in the nPP group versus the DDP group (88.2% vs. 59.4%, P = 0.001). Moreover, the ORR was also significantly higher in the nPP group than in the DDP group ( P = 0.013); and no statistically significant differences were found in the incidence of AEs among the groups ( P > 0.05). Conclusions In LACC treatment, the two cisplatin-based doublet chemotherapy regimens are associated with better outcomes, with the nab-paclitaxel plus cisplatin regimen showing better efficacy than the paclitaxel plus cisplatin regimen. Furthermore, the AEs associated with these regimens were deemed tolerable. These findings could provide a reference for the clinical treatment of LACC. However, further prospective studies are needed to verify it.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
牧夜白完成签到,获得积分10
刚刚
负责的爆米花完成签到,获得积分10
刚刚
清脆映真发布了新的文献求助10
刚刚
汉堡包应助cyw采纳,获得10
1秒前
MJ完成签到,获得积分10
1秒前
FashionBoy应助大饼卷肉采纳,获得10
1秒前
1秒前
2秒前
Ausna完成签到,获得积分10
2秒前
紫定能行完成签到,获得积分20
2秒前
2秒前
菜萝卜发布了新的文献求助10
3秒前
3秒前
鹏鹏哥发布了新的文献求助30
3秒前
量子星尘发布了新的文献求助10
4秒前
少年旭发布了新的文献求助10
4秒前
还没想好发布了新的文献求助10
4秒前
紫紫完成签到,获得积分10
5秒前
5秒前
Ing发布了新的文献求助10
6秒前
小璐璐呀发布了新的文献求助10
6秒前
7秒前
大饼卷肉完成签到,获得积分10
7秒前
传奇3应助谦让雨柏采纳,获得10
7秒前
方方发布了新的文献求助10
8秒前
鲤鱼睿渊完成签到,获得积分10
8秒前
8秒前
思源应助demonox采纳,获得10
8秒前
9秒前
9秒前
跳不起来的大神完成签到 ,获得积分10
10秒前
tq发布了新的文献求助10
10秒前
HHHHHH完成签到 ,获得积分20
10秒前
我是老大应助tiam采纳,获得10
10秒前
隐形曼青应助溯流光采纳,获得10
11秒前
11秒前
13秒前
13秒前
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974856
求助须知:如何正确求助?哪些是违规求助? 3519400
关于积分的说明 11198085
捐赠科研通 3255563
什么是DOI,文献DOI怎么找? 1797860
邀请新用户注册赠送积分活动 877208
科研通“疑难数据库(出版商)”最低求助积分说明 806219